ACHV stock: buy or sell?

ACHV stock price: $2.02 -2.42% At close on June 26th, 2019

Updated on:
June 26th, 2019

0

Achieve Life Sciences shares slipped -2.42% to $2.02 today. With Wednesday it's been 5 sliding days in a row, loosing $-0.40 (-15.44%). On June/24 ACHV plummed a hair-raising -9.95%.

Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients.

Should I buy ACHV stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. That's why is so important to choose your own trading plan that fits your character as inversor. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Currently, Achieve Life Sciences stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Achieve Life Sciences stock a buy?

Banks and financial institutions post stock ratings everyday. At Stocks2.com, we gathered 2 ratings published for ACHV stock in the last 30 days.

Is ACHV a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-6-14Maxim Groupn/aBuy
2019-6-11LADENBURG THALM/SH SHPositiveBuy

ACHV stock analysis

Daily outlook

Achieve Life Sciences shares slipped -2.42% to $2.02 today.

Achieve Life Sciences shares slipped -2.42% to $2.02 today. In the last 44 days when SMA100d and SMA200d crossed up, ACHV price slipped $-2.11 per share (-51.09%). ACHV marked a lower low and a lower high in the short term, defining a downward trend. Climbing above $2.89 would break this short term down trend and open possibilities for reversing this situation.

ACHV stock chart (daily)

Weekly outlook

Achieve Life Sciences closed this week at $2.02 and plummed a hair-raising -12.93%. Counting this, it's been 4 sliding weeks in a row, loosing $-2.19 (-56.74%). Late May ACHV rocketed an exceptional 8.31% in just one week.

Achieve Life Sciences finally dropped under the support line and now is sliding further looking for new supports. Since mid June, when ACHV stock price broke down the 40-weeks moving avarage line, it slid $-1.64 per share (-44.81%). Stocks under the 40-weeks moving average line are usually not recommended for average traders. Since SMA20w and SMA40w crossed up late April, ACHV price slid a -53.56%.

ACHV stock chart (weekly)

ACHV stock price history

ACHV stock went public on October 13th, 2000 with a price of $1,670.531. Since then, ACHV stock sliced a -99.90%, with a yearly average of -5.60%.

1: Adjusted price after possible price splits or reverse-splits.

ACHV stock historical price chart

ACHV stock reached 52-week highs at $6.10, and all-time highs 2005-10-18 with a price of 9979.2.

ACHV stock price target is $13.00

How much a stock will be priced tomorrow or next week is quite unpredictable However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' ACHV stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we found 2 price predictions for Achieve Life Sciences stock:
ACHV stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-6-14Maxim GroupInitiatesn/a$6.00-
2019-6-11LADENBURG THALM/SH SHReiterates$12.00$20.0066.7%
(in average)$12.00$13.008.0%
The price target for Achieve Life Sciences stock is $13.00, moving in a range between $20.00 and $6.00. In average, analysts' outlook on ACHV price forecast is positive, improving the target by a 8.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

After presenting its last earnings report on March, Achieve Life Sciences collapsed a bloodcurdling -17.55%. As soon as we get its actual EPS from the earnings report, we will update this review.
ACHV earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a-0.11n/a
2017-Q2-n/a-0.08n/a
2017-Q3-n/a-0.25n/a
2017-Q42018-03-01n/a-3.2n/a
2018-Q12018-05-09n/a-2.4n/a
2018-Q22018-08-08n/a-1.82n/a
2018-Q32018-11-07n/a-0.71n/a
2018-Q42019-03-14n/a-0.55n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

Compared to 2015, last anual turnover report draw a hair-raising slide of -72.13% to $5.06 M dollars. When comparing 2016 vs 2015, aligned with this, profit margin (that is, the net income divided by revenues) plummed a -305.13% to -397.65%.

ACHV annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$30 M-$-31.85 M-106.6%-
2014$27 M-9.25%$-26.24 M-96.8%-17.61%
2015$18 M-33.03%$-16.80 M-92.5%-35.97%
2016$5.06 M-72.13%$-20.13 M-397.6%19.81%

Quarterly financial results

Reported quarter earnings marked $-3.64 million with a profit margin of . Profit margin remained stable a 0.00% compared to previous quarter when profit margin was inf%. When comparing revenues to same quarter last year, Achieve Life Sciences sales marked a neutral movement and remained stable a nan%. Looking back to recent quarterly results, Achieve Life Sciences posted 7 negative quarters in a row.
ACHV quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2

Achieve Life Sciences ownership

When you are planning to buy a stock, it's always worth to check its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Achieve Life Sciences, 4.97% of all outstanding shares are owned by its staff.

In case of Achieve Life Sciences stock, 28.42% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for ACHV stock account 0.00%, no big difference from last month.

For a better understanding, the following table shows ownership data compared to other related stocks:

ACHV
Market cap$13.9 M
Total shares6.9 M
Float shares5.0 M
  - Institutional holdings (%)28.4%
  - Insider holdings (%)5.0%
Shares in short selling0.0%

ACHV summary

Wednesday, June 26th, 2019
Open$2.05
Close$2.02
Day range$1.92 - $2.10
Previous close$2.07
Session gain-2.42%
Average true range$0.32
50d mov avg$3.60
100d mov avg$3.12
200d mov avg$2.51
Daily patternlb06a
Weekly pattern lt01c

Achieve Life Sciences performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. In the following table, we compare Achieve Life Sciences performance to :
Stock3m6m12m
ACHVAchieve Life Scie...-37.46%68.33%-46.56%

Achieve Life Sciences competitors

Unfortunately, we could not find any public company that could be defined as Achieve Life Sciences competitor. This doesn't mean Achieve Life Sciences does not have any competitor in the market, it's just we could not detected it.